High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
Michael T. Lotze(University of Pittsburgh), Kevin J. Tracey
Cited by 2,494
Abstract
Related Papers
In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2.
Michael T. Lotze, Yvedt L. Matory, Stephen E. Ettinghausen et al.|The Journal of Immunology|1985|613